ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Organ Recovery Systems Wins Gold in 12th Annual Best in Biz Awards

Honored for Company’s Executive Team of the Year

Organ Recovery Systems (ORS) has been named a Gold winner in the Executive Team of the Year category for Best in Biz Awards 2022. The winners were selected based on scoring from independent judging panels comprised of journalists assembled from some of the most respected North American business magazines including Forbes to local newspapers, TV and radio outlets, and consumer, technology, and trade publications.

In giving the award, judges highlighted ORS leadership’s unique ability to solve major unaddressed market needs in transplantation. The panelists stated they were “impressed with the CEO's (David Kravitz’s) vision, the revolutionary technology it brought to life, and the potential it has to positively affect so many lives around the world. Most impressive, however, was the flawless coming together of so many departments and the remarkable execution of the various members of the (ORS) executive team – that's what teamwork is all about!”

The 12th annual awards program saw fierce competition among more than 700 entries from public and private companies of all sizes, industry sectors, and geographic regions throughout North America, ranging from some of the most iconic global brands and blue-chip companies in the global economy to innovative start-ups and resilient local companies. Judges underscored the winning companies’ visionary leadership, innovative strides in the use of new technologies, laudable employee diversity and inclusion programs and workplace best practices, community involvement, and monetary and time investments in the environment and corporate social responsibility programs.

“We are honored to be recognized with the Gold award for Executive Team of the Year,” said David Kravitz, CEO of ORS, and in turn honor the donor families and worldwide clinical community on the front lines of donation and transplantation whose dedication and compassion save many thousands of lives each year. “As a leadership team (and this extends to all in our company), we are grateful and privileged with the opportunity to support their incredible efforts.”

For the Best in Biz Awards official press release, visit: https://www.prweb.com/releases/2022/12/prweb19055748.htm

About Organ Recovery Systems

Organ Recovery Systems is a global market-leading provider of organ preservation products and services, supporting 320 transplant programs across 43 countries. Since its launch in 2003, LifePort Kidney Transporter has been employed in over 175,000 renal transplant procedures worldwide. Organ Recovery Systems’ proprietary LifePort platform has also been successfully designed to accommodate donor livers to help improve transplant outcomes for end-stage liver disease patients. LifePort Kidney and Liver Transporters are among a growing family of products and services developed by Organ Recovery Systems to support the Company’s mission of honoring donation as a gift of life, improving outcomes, and helping lower overall costs of care for end-stage organ disease.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.53
+4.12 (1.69%)
AAPL  269.74
+1.27 (0.47%)
AMD  245.19
+11.65 (4.99%)
BAC  53.69
+0.49 (0.92%)
GOOG  290.93
+11.23 (4.02%)
META  632.41
+10.70 (1.72%)
MSFT  504.92
+8.10 (1.63%)
NVDA  197.73
+9.58 (5.09%)
ORCL  238.65
-0.61 (-0.25%)
TSLA  445.57
+16.05 (3.74%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.